Achieve Life Sciences, Inc. is a clinical-stage biopharmaceutical company focused on developing cytisinicline, a plant-based compound, as a treatment for nicotine dependence, including smoking cessation. The company is pursuing FDA approval for cytisinicline and is exploring its use for additional methods of nicotine dependence beyond smoking. Achieve relies on third-party manufacturers for cytisinicline supply and is focused on commercialization efforts pending regulatory approval.
Q2 FY2026 — expected 2026-09-18
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-24 | 2025-12-31 | 0001193125-26-120690 | EDGAR | 78K words |
| 2025-03-11 | 2024-12-31 | 0000950170-25-036831 | EDGAR | — |
| 2024-03-28 | 2023-12-31 | 0000950170-24-038049 | EDGAR | — |
| 2023-03-16 | 2022-12-31 | 0001564590-23-003800 | EDGAR | — |
| 2022-03-10 | 2021-12-31 | 0001564590-22-009485 | EDGAR | — |
| 2021-03-11 | 2020-12-31 | 0001564590-21-012523 | EDGAR | — |
| 2020-03-13 | 2019-12-31 | 0001564590-20-010642 | EDGAR | — |
| 2019-03-14 | 2018-12-31 | 0001564590-19-007838 | EDGAR | — |
| 2018-03-01 | 2017-12-31 | 0001564590-18-004159 | EDGAR | — |
| 2017-02-23 | 2016-12-31 | 0001564590-17-002109 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-06 | 2025-09-30 | 0001193125-25-268074 | EDGAR | 51K words |
| 2025-08-07 | 2025-06-30 | 0000950170-25-104571 | EDGAR | — |
| 2025-05-13 | 2025-03-31 | 0000950170-25-069806 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0000950170-24-123375 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0000950170-24-096193 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0000950170-24-056929 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0000950170-23-062028 | EDGAR | — |
| 2023-08-14 | 2023-06-30 | 0000950170-23-042401 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0000950170-23-019680 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001564590-22-037646 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0001564590-22-029122 | EDGAR | — |
| 2022-05-12 | 2022-03-31 | 0001564590-22-019876 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-24 | 0001193125-26-120687 | EDGAR | 3K words |
| 2025-11-06 | 0001193125-25-268056 | EDGAR | — |
| 2025-10-07 | 0001193125-25-233581 | EDGAR | — |
| 2025-09-11 | 0001193125-25-201418 | EDGAR | — |
| 2025-08-07 | 0000950170-25-104569 | EDGAR | — |
| 2025-06-27 | 0000950170-25-091055 | EDGAR | — |
| 2025-06-06 | 0000950170-25-083214 | EDGAR | — |
| 2025-05-13 | 0000950170-25-069804 | EDGAR | — |
| 2025-03-11 | 0000950170-25-036830 | EDGAR | — |
| 2025-02-10 | 0000950170-25-017068 | EDGAR | — |
345 total filings indexed. 313 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000949858 |
| Ticker | ACHV |
| Exchange | Nasdaq |
| SIC | 2835: In Vitro & In Vivo Diagnostic Substances |
| Incorporated | DE |
| Website | https://www.achievelifesciences.com |
| Listed | 1995-10-12 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/ACHV (~200 tokens, structured JSON with cryptographic provenance)